TY - JOUR
T1 - Current classification for epidemic Kaposi's sarcoma (EKS)
AU - Moresco, L.
AU - Repetto, L.
AU - Gipponi, M.
AU - Di Somma, C.
AU - Lazzarin, A.
AU - Tambussi, G.
AU - Peszaros, P.
AU - Catturich, A.
AU - Percivale, P.
PY - 1994
Y1 - 1994
N2 - The Epidemic Kaposi's Sarcoma (EKS), was at first described in 1980 in USA homosexual men and it involves more frequently homosexual than I.V. drug abusers (40% and 8% respectively). The clinical onset of EKS is a proteans, being, often, the presenting sign of HIV infection. The lesions may appear at any time in the course of the disease. In order to assess the clinical course of the tumor and to propose a therapeutic planning, from June 1991 to Sept. 1992, 296 patients were staged according to the Tumor, Immune System, Systemic illness (TIS) classification (C.) prosed by Krown (ACGT - USA), and modified by our work group. As regards this C. our results did not show any significant difference on 5-year survival in T1-T2 subgroups. A slight, although not significant difference, was observed comparing S0, S1, S2 subgroups. Conversely, significant survival differences were observed in I0-I1 subgroups.
AB - The Epidemic Kaposi's Sarcoma (EKS), was at first described in 1980 in USA homosexual men and it involves more frequently homosexual than I.V. drug abusers (40% and 8% respectively). The clinical onset of EKS is a proteans, being, often, the presenting sign of HIV infection. The lesions may appear at any time in the course of the disease. In order to assess the clinical course of the tumor and to propose a therapeutic planning, from June 1991 to Sept. 1992, 296 patients were staged according to the Tumor, Immune System, Systemic illness (TIS) classification (C.) prosed by Krown (ACGT - USA), and modified by our work group. As regards this C. our results did not show any significant difference on 5-year survival in T1-T2 subgroups. A slight, although not significant difference, was observed comparing S0, S1, S2 subgroups. Conversely, significant survival differences were observed in I0-I1 subgroups.
KW - AIDS
KW - Cancer
KW - Epidemic Kaposi's sarcoma
KW - TNM
UR - http://www.scopus.com/inward/record.url?scp=0028609995&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028609995&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0028609995
VL - 13
SP - 247
EP - 252
JO - Journal of Experimental and Clinical Cancer Research
JF - Journal of Experimental and Clinical Cancer Research
SN - 0392-9078
IS - 3
ER -